XB3

Pharmaceutical products, namely, synthetic peptides and synthetic peptide fragments that promote the delivery of therapeutic agents to the brain, for use in the treatment of neurological disorders, pain, autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, and infectious diseases

Drug discovery services, research, development, engineering and testing of pharmaceuticals and substances, namely, peptides and peptide fragments that promote the delivery of therapeutic agents to the brain, for use in the treatment of neurological disorders, pain, autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, and infectious diseases